Alexandra Skorupa

Alexandra Skorupa is Medical Unit Director for Radioligand Therapies and Hematology at Novartis Germany. With a doctoral degree in Neurosciences from the Royal College of Surgeons in Ireland and the University of Montpellier, she is dedicated to translating scientific innovation into patient benefit. Since joining Novartis in 2012, she has helped advance groundbreaking cancer therapies in Germany, including the first CAR-T cell therapy and the introduction of radioligand therapy for prostate cancer.